O'CONNOR DANIEL J. (Chief Executive Officer) reported 1 transaction at ZYVERSA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/14/2022ACC: 0001493152-22-035477
DirectorOfficer· Chief Executive Officer
Since Dec 2021
+1.56M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
1.56M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.38M
Price / share
—
Trade value
—
% of position
New position
12/12/2022
0.00→1.38M
Total
Net shares
+1.38M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/12/2022 | J · J | +1.38M | — | — | New position | 0.00 | 1.38M |
| Total | +1.38M | $0.00 | ||||||
Derivative Transactions3
Series A Convertible Preferred Stock
Direct
Converts to
Common Stock
1.75K shares
Shares
+1.75K
Strike price
10.00
Held after
1.75K
Exercisable
—
12/12/2022
Warrant (right to buy)
Direct
Converts to
Common Stock
1.75K shares
Shares
+1.75K
Strike price
11.50
Held after
1.75K
Exercisable
—
12/12/2022
Warrant (right to buy)
Indirect
Converts to
Common Stock
177.20K shares
Shares
+177.20K
Strike price
11.50
Held after
177.20K
Exercisable
—
12/12/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Direct | Common Stock1.75K shares | 12/12/2022 | J · J | +1.75K | 10.00 | — | 1.75K |
| Warrant (right to buy) Direct | Common Stock1.75K shares | 12/12/2022 | J · J | +1.75K | 11.50 | — | 1.75K |
| Warrant (right to buy) Indirect | Common Stock177.20K shares | 12/12/2022 | J · J | +177.20K | 11.50 | — | 177.20K |